References
Neonakis IK, Gitti Z, Petinaki E, Maraki S, Spandidos DA (2007) Evaluation of the GenoType MTBC assay for differentiating 120 clinical Mycobacterium tuberculosis complex isolates. Eur J Clin Microbiol Infect Dis 26:151–152
Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S (2005) Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 43:3699–3703
No authors listed (2006) Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 10;81:430–432
Texier-Maugein J, Mormede M, Fourche J, Bebear C (1987) In vitro activity of four fluoroquinolones against eighty-six isolates of Mycobacteria. Eur J Clin Microbiol 6:584–586
Truffot-Pernot C, Ji B, Grosset J (1991) Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments. Tubercle 72:57–64
Trakada G, Tsiamita M, Spiropoulos K (2004) Drug-resistance of Mycobacterium tuberculosis in Patras, Greece. Monaldi Arch Chest Dis 61:65–70
Kanavaki S, Mantadakis E, Nikolaou S, Papavassiliou A, Karambela S, Anagnostou S, Falagas ME, Samonis G (2006) Resistance of Mycobacterium tuberculosis isolates in different populations in Greece during 1993–2002. Int J Tuberc Lung Dis 10:559-564
World Health Organization (2004) Drug resistance in the world. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1999-2002. Third global report. WHO, Geneva, Switzerland
Acknowledgements
The experiments comply with the current laws of Greece.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Neonakis, I.K., Gitti, Z., Baritaki, M. et al. Resistance status of Mycobacterium tuberculosis on the island of Crete, Greece. Eur J Clin Microbiol Infect Dis 26, 607–609 (2007). https://doi.org/10.1007/s10096-007-0341-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-007-0341-1